SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (2663)9/28/2001 11:05:20 AM
From: scaram(o)ucheRead Replies (2) of 4974
 
Why the heck didn't they just buy KDUS? For 4M shares, they get $26M. In addition, the overhang of the offering was contributive (is that a word?) to the share retreat from $11.

Buy KDUS and you get $24M, potential royalty flow from OSIP-proprietary or (not both) OSIP-Solvay, a large hunk of Axiom, and miscellany.

Six weeks ago, when the secondary concept was floated? Probably could have had it for 3M shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News